Biomm S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was BRL 104.95 million compared to BRL 107.09 million a year ago. Net loss was BRL 92.56 million compared to BRL 80.26 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 BRL | -15.65% |
|
-4.76% | +138.75% |
May. 16 | Biomm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
1st Jan change | Capi. | |
---|---|---|
+138.75% | 321M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- BIOM3 Stock
- News Biomm S.A.
- Biomm S.A. Reports Earnings Results for the Full Year Ended December 31, 2022